Scientists create detailed map of colon cells to unlock disease secrets
NCT ID NCT05195502
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study took small tissue samples from the colons of 40 people during routine colonoscopies. Using advanced genetic techniques, researchers created a detailed map of the different cell types and their gene activity. The goal is to better understand how colon diseases and conditions like type 2 diabetes develop.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this detailed map of colon cells could help researchers understand how colon diseases and diabetes develop, potentially guiding future treatments.
- What could go wrong
- This is a small, completed observational study that only describes cells—it does not test any treatment. The findings may not directly lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
40 people
The number who actually took part.
- Started
-
Jul 2022
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Citizens aged 50 to 74 are invited to partake in screening for bowel cancer every second year. Patients who accept referral based on a positive fecal immunochemical test, will be invited to participate in this study
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients referred for out-patient colonoscopy as a result of positive hemoccult. * Patients able to read and understand danish. * Patients able to give informed consent. * Patients of Scandinavian ethnicity. Exclusion Criteria: * Previous large bowel resections * Suspicion pre or intraoperatively of benign or malignant disease of the colon * Known inflammatory bowel disease. * Immuno-modulation treatment * Chemotherapy. * Daily smoking * \> 21 weekly units of alcohol * \< 18 years of age
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bispebjerg University Hospital
Copenhagen, 2720, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill takes aim at blood sugar in diabetes
- Home c-peptide tests could reveal hidden insulin production in diabetes
- Can a cheap Anti-Inflammatory drug calm ulcerative colitis?
- Brain scans may predict who is most at risk for dangerous low blood sugar
- Diabetes devices put to the test: can home monitors match lab accuracy?
- Can early symptom relief predict who stays on IBD biologic?